Azenta, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024
May 08, 2024 at 04:05 pm EDT
Share
Azenta, Inc. reported earnings results for the second quarter and six months ended March 31, 2024. For the second quarter, the company reported revenue was USD 159.13 million compared to USD 148.4 million a year ago. Net loss was USD 136.88 million compared to USD 4.93 million a year ago. Basic loss per share from continuing operations was USD 2.47 compared to USD 0.03 a year ago. Diluted loss per share from continuing operations was USD 2.47 compared to USD 0.03 a year ago. Basic loss per share was USD 2.47 compared to USD 0.07 a year ago. Diluted loss per share was USD 2.47 compared to USD 0.07 a year ago.
For the six months, revenue was USD 313.45 million compared to USD 326.77 million a year ago. Net loss was USD 152.6 million compared to USD 16.16 million a year ago. Basic loss per share from continuing operations was USD 2.72 compared to USD 0.19 a year ago. Diluted loss per share from continuing operations was USD 2.72 compared to USD 0.19 a year ago. Basic loss per share was USD 2.72 compared to USD 0.23 a year ago. Diluted loss per share was USD 2.72 compared to USD 0.23 a year ago.
Azenta, Inc. is a provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Companyâs segments include Sample Management Solutions, Multiomics and B Medical Systems. The Sample Management Solutions segment offers end-to-end sample management products and services, including sample and repository services and core products (automated stores, cryogenic systems, automated sample tube, and consumables and instruments). The Multiomics segment provides genomic and other sample analysis services, including gene sequencing and gene synthesis. B Medical Systems segment is focused on the manufacturing and distribution of temperature-controlled storage and transportation solutions in international markets to governments, health institutions, and non-government organizations. It provides products and services through its brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey, and B Medical Systems.